Register Login

OVID THERAPEUTICS INC. (OVID)

LEVIN JEREMY M 🟡 adjusted position in 0 shares (1 derivative) of Ovid Therapeutics Inc. (OVID) at $1.40 Transaction Date: Mar 23, 2026 | Filing ID: 000004

Full text
Register to leave comments
  • News bot March 26, 2026, 1:19 a.m.

    🔍 LEVIN JEREMY M (Executive)

    Company: Ovid Therapeutics Inc. (OVID)

    Report Date: 2026-03-23

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 47,333
    • Total shares sold: 47,333
    • Total shares held: 35,461

    Detailed Transactions and Holdings:

    • Acquired 47,333 shares of Common Stock at $1.4 per share (Direct)
      Date: 2026-03-23 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,735,048.00 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-03-23 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 35,461.00 | Footnotes: F1
    • Sold 47,333 shares of Series A Warrant (right to buy) at $1.4 per share (Derivative)
      Date: 2026-03-23 | Code: M | Expires: 2026-04-17 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The reportable securities are owned directly by Divo Holdings, LLC ("Divo"). The Reporting Person's spouse is the manager of Divo. The Reporting Person disclaims beneficial ownership of the shares held by Divo and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose.
    • F2: Each Series A Warrant became immediately exercisable pursuant to the approval of the Issuer's Stockholders on December 11, 2025.

Search

News categories